BIOMOLECULAR LIFE HOLDINGS, INC.
Close on Oct 19, 2026
- Market cap
- $67.51M
- P/E (TTM)
- –
- Dividend yield
- –
Earnings
Quarterly results announced on Form 8-K, Item 2.02
No earnings releases found
Biomolecular Life has not filed an earnings release (Form 8-K, Item 2.02) that we could match to a fiscal quarter.
Press releases
Announcements Biomolecular Life filed with the SEC
VG LIFE SCIENCES, INC.
Event dated Mar 29, 2016, from SEC EDGAR
FORM 8-K
Event dated May 21, 2015, from SEC EDGAR
CURRENT REPORT
Event dated Mar 10, 2015, from SEC EDGAR
CURRENT REPORT ON FORM 8-K
Event dated Jan 15, 2015, from SEC EDGAR
CURRENT REPORT ON FORM 8-K
Event dated Sep 5, 2014, from SEC EDGAR
Current report on Form 8-K
Event dated Jan 21, 2009, from SEC EDGAR
Current report on Form 8-K
Event dated Aug 18, 2008, from SEC EDGAR
Current report on Form 8-K
Event dated Aug 18, 2008, from SEC EDGAR
Current report on Form 8-K
Event dated Jul 1, 2007, from SEC EDGAR
Current report on Form 8-K
Event dated Mar 5, 2008, from SEC EDGAR
Current report on Form 8-K
Event dated Dec 3, 2007, from SEC EDGAR
Current report on Form 8-K
Event dated Jul 5, 2007, from SEC EDGAR
Current report on Form 8-K
Event dated Sep 18, 2007, from SEC EDGAR
Current report on Form 8-K
Event dated Jun 19, 2007, from SEC EDGAR
Current report on Form 8-K
Event dated Mar 2, 2007, from SEC EDGAR